CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,519,090
- in 5 filings, $1.5M under 10b5-1 plans
Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-22 | GORDON CARL L Director | Sale | −7,673 | $26.47 | $203K | 2,432,285 |
| 2021-03-22 | ORBIMED ADVISORS LLC Director | Sale | −7,673 | $26.47 | $203K | 2,432,285 |
| 2021-03-19 | GORDON CARL L Director | Sale | −21,275 | $26.47 | $563K | 2,439,958 |
| 2021-03-19 | ORBIMED ADVISORS LLC Director | Sale | −21,275 | $26.47 | $563K | 2,439,958 |
| 2021-03-18 | ORBIMED ADVISORS LLC Director | Sale | −6,059 | $28.03 | $170K | 2,461,233 |
| 2021-03-18 | GORDON CARL L Director | Sale | −6,059 | $28.03 | $170K | 2,461,233 |
| 2021-03-17 | ORBIMED ADVISORS LLC Director | Sale | −18,790 | $28.43 | $534K | 2,467,292 |
| 2021-03-17 | GORDON CARL L Director | Sale | −18,790 | $28.43 | $534K | 2,467,292 |
| 2021-03-16 | ORBIMED ADVISORS LLC Director | Sale | −41,353 | $27.72 | $1.1M | 2,486,082 |
| 2021-03-16 | GORDON CARL L Director | Sale | −41,353 | $27.72 | $1.1M | 2,486,082 |
| 2021-03-15 | ORBIMED ADVISORS LLC Director | Sale | −89,210 | $29.14 | $2.6M | 2,527,435 |
| 2021-03-15 | GORDON CARL L Director | Sale | −89,210 | $29.14 | $2.6M | 2,527,435 |
| 2021-03-12 | ORBIMED ADVISORS LLC Director | Sale | −90,521 | $30.29 | $2.7M | 2,616,645 |
| 2021-03-12 | GORDON CARL L Director | Sale | −90,521 | $30.29 | $2.7M | 2,616,645 |
| 2021-03-11 | ORBIMED ADVISORS LLC Director | Sale | −58,551 | $33.04 | $1.9M | 2,707,166 |
| 2021-03-11 | GORDON CARL L Director | Sale | −58,551 | $33.04 | $1.9M | 2,707,166 |
| 2021-02-01 | Piscitelli Dominic Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2021-02-01 | Multani Pratik S Chief Medical Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2021-02-01 | Chacko Jacob President and CEO | Grant or award · Stock Option (right to buy) | +280,000 | 280,000 | ||
| 2020-11-04 | Topspin Fund L.P. 10% owner | Sale | −2,268,750 | 1,100,446 |
Page 15 of 18 · 353 trades